NCT07501416

Brief Summary

This randomized, sham-controlled clinical trial aims to evaluate the effectiveness of high-intensity laser therapy (HILT) combined with exercise on pain, functional status, disability, and ultrasonographic findings in patients with hemiplegic shoulder pain following stroke.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Apr 2026Jan 2027

First Submitted

Initial submission to the registry

March 22, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 30, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2027

Last Updated

July 28, 2026

Status Verified

July 1, 2026

Enrollment Period

9 months

First QC Date

March 22, 2026

Last Update Submit

July 26, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Shoulder Pain and Disability Index (SPADI)

    The Shoulder Pain and Disability Index (SPADI) was used to evaluate shoulder-related pain and functional impairment. The index consists of 13 items divided into two subscales: pain (5 items) and disability (8 items). Each item is scored on a 0-10 numerical rating scale, where 0 indicates "no pain/difficulty" and 10 indicates "worst imaginable pain/so difficult it requires help." The total score is calculated by averaging the subscale scores and converting them to a percentage, ranging from 0 to 100. Higher scores represent greater levels of pain and disability. The SPADI is a widely recognized tool with high internal consistency and responsiveness to clinical changes in shoulder conditions.

    Baseline and Week 4

  • Functional Independence Measure (FIM)

    Assesses functional independence in activities of daily living. Includes motor and total scores. The functional status of the participants was evaluated using the Functional Independence Measure (FIM). The FIM consists of 18 items, categorized into two main domains: Motor FIM (13 items): Assessing self-care, sphincter control, transfers, and locomotion (score range: 13-91). Cognitive FIM (5 items): Assessing communication and social cognition (score range: 5-35). Each item is scored on a 7-point Likert scale, ranging from 1 (total assistance) to 7 (complete independence). Total scores range from 18 to 126, where higher scores indicate greater functional independence.

    Baseline and Week 4

  • Ultrasonographic Assessment

    This description refers to the Ultrasonographic Evaluation of the shoulder. In a Method section, it is important to specify that the exam was performed by a specialist and to list the specific structures visualized. Here is the professional English text for your article: Ultrasonographic Evaluation All participants underwent a standardized musculoskeletal ultrasound (US) examination of the affected shoulder, performed by an experienced \[radiologist/physiatrist\] using a \[Insert Brand, e.g., GE Voluson\] system with a high-frequency linear transducer. The examination followed the European Society of Musculoskeletal Radiology (ESSR) guidelines. The sonographic assessment included: Tendon Pathology: Evaluation of the supraspinatus, infraspinatus, and subscapularis tendons for signs of tendinosis, calcifications, and partial or full-thickness tears. The long head of the biceps tendon was also assessed for tenosynovitis or subluxation

    Baseline and Week 4

Secondary Outcomes (6)

  • Shoulder Range of Motion (ROM)

    Baseline and Week 4

  • Modified Ashworth Scale

    Baseline and Week 4

  • Brunnstrom Recovery Stages

    Baseline and Week 4

  • Pressure Pain Threshold

    Baseline and Week 4

  • Acromiohumeral Distance

    Baseline and Week 4

  • +1 more secondary outcomes

Study Arms (2)

High-Intensity Laser Therapy + Exercise

EXPERIMENTAL

Participants will receive high-intensity laser therapy combined with a structured exercise program.

Device: High-Intensity Laser Therapy (HILT)Other: Exercise therapy

Sham Laser Therapy + Exercise

SHAM COMPARATOR

Participants will receive sham laser therapy combined with the same exercise program.

Other: Exercise therapyDevice: Sham Laser Therapy

Interventions

High-intensity laser therapy will be applied using a 1064 nm wavelength laser device with a peak power up to 3 kW. Each session will deliver approximately 2500 Joules of over 10 minutes. The treatment will be applied to the supraspinatus, deltoid, upper trapezius, pectoralis minor, and biceps tendon regions. The treatment protocol includes fast and slow scanning phases and will be administered 5 days per week for 4 weeks (total 20 sessions).

High-Intensity Laser Therapy + Exercise

Participants will undergo a standardized rehabilitation program including passive, active-assisted, and active range-of-motion exercises. Exercises will be performed in 3 sets of 10 repetitions daily, 5 days per week for 4 weeks.

High-Intensity Laser Therapy + ExerciseSham Laser Therapy + Exercise

The same laser device will be used without active energy emission. The procedure, duration, and application areas will be identical to the active laser therapy to maintain blinding.

Sham Laser Therapy + Exercise

Eligibility Criteria

Age30 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 30-75 years
  • Hemiplegic shoulder pain after stroke
  • Stroke within last 6 months
  • VAS ≥ 3 for pain
  • Medically stable

You may not qualify if:

  • Neurological disorders (MS, Parkinson, etc.)
  • Recent shoulder surgery/injection
  • Botulinum toxin (last 6 months)
  • Malignancy
  • Pregnancy
  • Epilepsy or photosensitivity
  • Cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya Health Sciences University

Kütahya, 43000, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Exercise Therapy

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Fatima YAMAN, Assoc. Prof.

    Kutahya Health Sciences University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fatima YAMAN, Assoc. Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

March 22, 2026

First Posted

March 30, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

January 30, 2027

Last Updated

July 28, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations